Trial Profile
A phase I trial of an intranasal influenza vaccine.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Oct 2011
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Therapeutic Use
- 06 Oct 2011 New trial record